METHOD FOR DETERMINING THE PROGNOSIS OF PANCREATIC CANCER

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160244845A1
SERIAL NO

15027121

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

An in vitro method for determining the prognosis of pancreatic cancer in a patient includes the following steps: a) measuring the expression level of at least one gene chosen from the group consisting of: ACOX-1, TNFRSF10B, LYN, HIF1A, UBE2H, PARP2, ABCC1, ABCC3, IGJ and RPS23 or homologous genes, in a blood sample of the patient, b) predicting the outcome of the pancreatic cancer in the patient. a kit specifically designed to carry out such a method is also described.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AB SCIENCEPARIS
ACOBIOMFRENCH GRABEEL GRASSE ALPES-MARITIMES

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
KINET, Jean-Pierre Lexington, US 66 632
MOUSSY, Alain PARIS, FR 75 376
PIQUEMAL, David SAINT CHRISTOL LES ALES, FR 5 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation